Expression of MT-CO3 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

MT-CO3 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 7896.34

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

10294.0

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	35234.0
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	24427.1
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	23553.8
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	23328.4
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	21805.7
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	20610.4
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	19835.6
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	19424.7
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	19099.8
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	17095.6
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	17058.2
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	16503.0
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	16498.2
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	16184.9
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	16031.9
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	15944.1
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	15913.6
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	15640.4
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	15317.5
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	15174.7
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	15118.6
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	15084.1
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	14953.0
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	14928.8
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	14822.0
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	14804.1
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	14739.7
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	14722.7
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	14457.1
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	14440.7
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	14263.0
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	14179.9
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	14147.8
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	14062.2
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	13969.8
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	13726.1
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	13665.2
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	13548.6
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	13484.5
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	13448.5
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	13123.1
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	12907.7
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	12903.2
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	12478.9
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	12424.4
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	12417.4
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	12356.1
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	12202.8
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	12189.9
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	12068.5
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	11998.1
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	11907.4
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	11758.5
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	11466.9
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	11414.7
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	11218.7
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	11140.8
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	11098.3
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	10984.6
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	10969.1
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	10698.5
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	10655.5
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	10544.7
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	10511.0
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	10433.5
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	10139.4
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	9961.8
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	9958.1
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	9843.2
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	9811.5
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	9532.0
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	9438.1
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	9375.7
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	9330.8
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	8895.0
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	8887.7
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	8645.2
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	8595.1
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	8374.6
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	8361.1
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	8340.3
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	8324.3
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	8284.1
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	8248.9
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	8219.7
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	8112.5
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	8005.8
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	7964.1
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	7919.6
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	7873.0
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	7796.9
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	7650.7
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	7576.0
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	7525.6
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	7462.3
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	7411.7
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	7345.4
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	7284.3
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	6993.5
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	6963.7
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	6706.1
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	6698.2
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	6580.7
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	6552.3
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	6550.5
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	6437.0
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	6236.8
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	6230.3
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	6133.1
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	6049.2
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	5981.7
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	5973.6
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	5940.1
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	5760.1
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	5752.6
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	5716.5
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	5624.7
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	5502.5
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	5368.9
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	5336.7
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	5245.5
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	5137.4
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	4692.0
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	4523.4
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	4503.2
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	4396.0
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	4320.9
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	4299.8
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	4038.8
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	3598.1
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	3399.9
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	3249.2
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	2964.9
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	2887.1
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	2718.1
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	2524.1
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	2359.4
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	2232.7
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	2085.2
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	1877.9
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	1696.2
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

MT-CO3 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 6924.48

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

7864.0

Number of samples

Samples

Sample	Description	pTPM
AK134	N, NA, stage:NA, dead, 360 days	18607.8
AK102	N, NA, stage:NA, alive, 1740 days	17371.9
AK213	N, NA, stage:NA, alive, 2010 days	15094.1
AK226	N, NA, stage:NA, dead, 360 days	13770.1
AK218	N, NA, stage:NA, dead, 180 days	13551.3
AK015	N, NA, stage:NA, alive, 720 days	13153.0
AK030	N, NA, stage:NA, dead, 120 days	12840.5
AK158	N, NA, stage:NA, dead, 360 days	12650.5
AK006	N, NA, stage:NA, dead, 360 days	12618.2
AK005	N, NA, stage:NA, dead, 240 days	12516.3
AK099	N, NA, stage:NA, dead, 420 days	12404.7
AK041	N, NA, stage:NA, alive, 810 days	11830.2
AK079	N, NA, stage:NA, dead, 210 days	11235.0
AK173	N, NA, stage:NA, dead, 180 days	11107.3
AK133	N, NA, stage:NA, dead, 360 days	10983.1
AK085	N, NA, stage:NA, alive, 660 days	10552.9
AK002	N, NA, stage:NA, dead, 570 days	10306.4
AK195	N, NA, stage:NA, dead, 390 days	9576.2
AK205	N, NA, stage:NA, dead, 120 days	9448.6
AK124	N, NA, stage:NA, alive, 1920 days	8883.0
AK167	N, NA, stage:NA, dead, 180 days	8709.2
AK227	N, NA, stage:NA, alive, 300 days	8395.7
AK035	N, NA, stage:NA, dead, 210 days	8273.7
AK043	N, NA, stage:NA, alive, 660 days	8239.9
AK149	N, NA, stage:NA, dead, 420 days	8196.7
AK066	N, NA, stage:NA, alive, 960 days	7965.7
AK165	N, NA, stage:NA, alive, 360 days	7813.3
AK081	N, NA, stage:NA, dead, 180 days	7809.6
AK103	N, NA, stage:NA, alive, 1320 days	7759.1
AK088	N, NA, stage:NA, dead, 360 days	7722.6
AK183	N, NA, stage:NA, alive, 360 days	7325.7
AK089	N, NA, stage:NA, dead, 330 days	7283.6
AK076	N, NA, stage:NA, alive, 660 days	7191.0
AK091	N, NA, stage:NA, dead, 210 days	6657.9
AK156	N, NA, stage:NA, dead, 330 days	6535.4
AK236	N, NA, stage:NA, dead, 360 days	5930.5
AK142	N, NA, stage:NA, alive, 90 days	5848.5
AK053	N, NA, stage:NA, dead, 300 days	5536.4
AK123	N, NA, stage:NA, dead, 180 days	5138.1
AK051	N, NA, stage:NA, dead, 360 days	5053.8
AK117	N, NA, stage:NA, dead, 210 days	4907.8
AK153	N, NA, stage:NA, dead, 240 days	4831.4
AK185	N, NA, stage:NA, alive, 330 days	4815.2
AK068	N, NA, stage:NA, alive, 360 days	4660.1
AK003	N, NA, stage:NA, dead, 600 days	4559.4
AK199	N, NA, stage:NA, alive, 1860 days	4158.1
AK071	N, NA, stage:NA, dead, 540 days	4018.8
AK072	N, NA, stage:NA, dead, 150 days	3972.2
AK100	N, NA, stage:NA, alive, 960 days	3946.7
AK188	N, NA, stage:NA, alive, 420 days	3606.6
AK049	N, NA, stage:NA, dead, 180 days	3201.6
AK098	N, NA, stage:NA, dead, 660 days	3014.5
AK055	N, NA, stage:NA, dead, 240 days	2929.1
AK139	N, NA, stage:NA, dead, 270 days	2807.6
AK231	N, NA, stage:NA, dead, 240 days	2657.6
AK178	N, NA, stage:NA, dead, 240 days	2615.2
AK216	N, NA, stage:NA, dead, 360 days	2041.2
AK074	N, NA, stage:NA, alive, 300 days	1481.6
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0206330003	Tumor	N/A
CPT0186100003	Tumor	N/A
CPT0123530003	Tumor	N/A
CPT0201710003	Tumor	N/A
CPT0216920008	Tumor	N/A
CPT0218890004	Tumor	N/A
CPT0224390004	Tumor	N/A
CPT0204390003	Normal	N/A
CPT0093590003	Tumor	N/A
CPT0167750004	Tumor	N/A
CPT0204400003	Normal	N/A
CPT0079790003	Tumor	N/A
CPT0218690004	Tumor	N/A
CPT0204370003	Normal	N/A
CPT0161730003	Tumor	N/A
CPT0168720003	Tumor	N/A
CPT0206880003	Tumor	N/A
CPT0189650004	Tumor	N/A
CPT0204350003	Normal	N/A
CPT0168380003	Tumor	N/A
CPT0205890003	Tumor	N/A
CPT0217880003	Tumor	N/A
CPT0206560003	Tumor	N/A
CPT0087680003	Tumor	N/A
CPT0206000004	Tumor	N/A
CPT0218670003	Tumor	N/A
CPT0204340003	Normal	N/A
CPT0189850004	Tumor	N/A
CPT0224330003	Tumor	N/A
CPT0218330004	Tumor	N/A
CPT0167640003	Tumor	N/A
CPT0002410011	Tumor	N/A
CPT0093450003	Tumor	N/A
CPT0206110003	Tumor	N/A
CPT0217430008	Tumor	N/A
CPT0217000004	Tumor	N/A
CPT0196850003	Tumor	N/A
CPT0189250003	Tumor	N/A
CPT0189570004	Tumor	N/A
CPT0162020003	Tumor	N/A
CPT0167530003	Tumor	N/A
CPT0207030003	Tumor	N/A
CPT0127420003	Tumor	N/A
CPT0205670004	Tumor	N/A
CPT0208980003	Tumor	N/A
CPT0206780003	Tumor	N/A
CPT0182500003	Tumor	N/A
CPT0217710008	Tumor	N/A
CPT0168830003	Tumor	N/A
CPT0182550003	Tumor	N/A
CPT0189460003	Tumor	N/A
CPT0167860004	Tumor	N/A
CPT0125220003	Tumor	N/A
CPT0171580008	Tumor	N/A
CPT0087730003	Tumor	N/A
CPT0104330003	Tumor	N/A
CPT0168590003	Tumor	N/A
CPT0205450004	Tumor	N/A
CPT0219080004	Tumor	N/A
CPT0087570003	Tumor	N/A
CPT0162140003	Tumor	N/A
CPT0175060003	Tumor	N/A
CPT0205780003	Tumor	N/A
CPT0218960004	Tumor	N/A
CPT0064650003	Tumor	N/A
CPT0125570003	Tumor	N/A
CPT0190360004	Tumor	N/A
CPT0206670004	Tumor	N/A
CPT0204380003	Normal	N/A
CPT0092440003	Tumor	N/A
CPT0162100003	Tumor	N/A
CPT0221180003	Tumor	N/A
CPT0225760003	Tumor	N/A
CPT0093510003	Tumor	N/A
CPT0190240004	Tumor	N/A
CPT0228220003	Tumor	N/A
CPT0204410003	Normal	N/A
CPT0224540004	Tumor	N/A
CPT0209440003	Tumor	N/A
CPT0089150003	Tumor	N/A
CPT0204360003	Normal	N/A
CPT0168080003	Tumor	N/A
CPT0078580003	Tumor	N/A
CPT0127480003	Tumor	N/A
CPT0204420003	Normal	N/A
CPT0218830004	Tumor	N/A
CPT0225730003	Tumor	N/A
CPT0093360003	Tumor	N/A
CPT0168270003	Tumor	N/A
CPT0206450003	Tumor	N/A
CPT0207090003	Tumor	N/A
CPT0104220003	Tumor	N/A
CPT0224600003	Tumor	N/A
CPT0087950003	Tumor	N/A
CPT0204330003	Normal	N/A
CPT0199770003	Tumor	N/A
CPT0205570003	Tumor	N/A
CPT0093550003	Tumor	N/A
CPT0167970003	Tumor	N/A
CPT0182580003	Tumor	N/A
CPT0168480003	Tumor	N/A
CPT0206230003	Tumor	N/A
CPT0189750004	Tumor	N/A
CPT0217100003	Tumor	N/A
CPT0064890003	Tumor	N/A
CPT0217190003	Tumor	N/A
CPT0218770003	Tumor	N/A
CPT0125510003	Tumor	N/A
CPT0217060003	Tumor	N/A
CPT0071100003	Tumor	N/A
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA042788
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade